Growth of Infants Fed With BabyNes System

This study is currently recruiting participants.
Verified May 2013 by Nestlé
Sponsor:
Information provided by (Responsible Party):
Nestlé
ClinicalTrials.gov Identifier:
NCT01585142
First received: April 24, 2012
Last updated: May 15, 2013
Last verified: May 2013
  Purpose

The purpose of this study is to assess the growth of infants fed with BabyNes System, compared to the World Health Organization Reference, during the first four months of life.


Condition Intervention
Dietary Modification
Other: Test formula

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Assessment of Growth of Infants Fed With BabyNes System (Single-serve Formulas, Adaptative System)

Further study details as provided by Nestlé:

Primary Outcome Measures:
  • z-score weight-for-age (WHO Child Growth Standards) [ Time Frame: 4 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Growth [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
    BMI for age z-scores, weight for length z-scores, length for age z-scores, head circumference for age z-scores

  • Compliance [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
    Volume of formula intake

  • Morbidity [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
    Number of infants with adverse events


Estimated Enrollment: 80
Study Start Date: April 2012
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: BabyNes system formula Other: Test formula
Infant Formulas in powder in single-serve capsules (with a machine for dispensing, four consecutive formulas with customized composition
Other Name: BabyNes System

  Eligibility

Ages Eligible for Study:   up to 14 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy newborn
  • Full term newborn (≥ 37 weeks gestation)
  • Birth weight ≥ 2500 g and ≤ 4500 g
  • Newborn from birth to 14 days of age at the time of enrollment
  • The newborn's mother has voluntarily elected to exclusively formula feed her newborn
  • Having obtained his/her signed legal representative's informed consentHealthy newborn infant

Exclusion Criteria:

  • Congenital illness or malformation that may affect normal growth (especially immunodeficiency)
  • Newborn whose mother's BMI was abnormal (<18.5 or >30kg/m2) at start of pregnancy
  • Newborn whose mother has diabetes of type-1 or type-2
  • Newborn whose mother has a chronic infectious disease
  • Newborn whose parents / caregivers cannot be expected to comply with treatment
  • Newborn currently participating in another nutritional interventional clinical trial (except for vaccination studies)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01585142

Contacts
Contact: Delphine Egli +41219243238 Delphine.Egli@nestle.com

Locations
Switzerland
Universitäts-Kinderspital beider Basel (UKBB) Recruiting
Basel, Switzerland, 4031
Contact: Raoul I. Furlano, Dr med            
Principal Investigator: Raoul I. Furlano, Dr med.            
Hôpital des enfants Recruiting
Geneva, Switzerland, 1205
Contact: Dominique Belli, Prof Dr med            
Principal Investigator: Dominique Belli, Prof Dr med            
CHUV Unité de Gastroentérologie Pédiatrique DMCP-BH11 Active, not recruiting
Lausanne, Switzerland, 1011
Pädiatrische Gastroenterologie und Hepatologie Kinderspital Recruiting
Luzern, Switzerland, 6000
Contact: Johannes Spalinger, Dr med            
Principal Investigator: Johannes Spalinger, Dr med.            
Sponsors and Collaborators
Nestlé
Investigators
Principal Investigator: Johannes Spalinger, Dr med. Pädiatrische Gastroenterologie und Hepatologie Kinderspital
  More Information

No publications provided

Responsible Party: Nestlé
ClinicalTrials.gov Identifier: NCT01585142     History of Changes
Other Study ID Numbers: 11.18.INF
Study First Received: April 24, 2012
Last Updated: May 15, 2013
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Food Habits
Habits

ClinicalTrials.gov processed this record on May 22, 2013